The Most Worrisome Study at AHA 2024
A trial on percutaneous left atrial appendage closure combined with AF ablation vs ablation and DOACs raises concerns about a potential wave of overuse of a new combo procedure.| Medscape
A trial on percutaneous left atrial appendage closure combined with AF ablation vs ablation and DOACs raises concerns about a potential wave of overuse of a new combo procedure.| Medscape
Will reassuring safety data and a good efficacy signal increase use of digoxin in heart failure? John Mandrola MD reviews the DIGIT- HF trial from the 2025 European Society of Cardiology congress.| Medscape
Seemingly conflicting data from trials on whether to use beta-blockers post myocardial infarction point in the same direction, argues John Mandrola, MD, in reviewing BETAMI/DANBLOCK and REBOOT.| Medscape
An expanded indication based on a dubious post hoc analysis of GUIDE-HF should not allow the CardioMEMS HF system to become the therapeutic fashion, writes John Mandrola, MD.| Medscape
